N-cyclohexyl-2-[5-(4-pyridyl)-4-(p-tolyl)-4H-1,2,4-triazol-3-ylsulfanyl]-acetamide dihydrate: Synthesis, experimental, theoretical characterization and biological activities

dc.contributor.authorOrek, Cahit
dc.contributor.authorKoparir, Pelin
dc.contributor.authorKoparir, Metin
dc.date.accessioned2026-08-12T17:48:47Z
dc.date.issued2012
dc.departmentFırat Üniversitesi
dc.description.abstractThe triazol compound N-cyclohexyl-2[5-(4-pyridyl)-4-(p-tolyl)-4H-1,2,4-triazol-3-ylsulfanyl]-acetamide dihydrate has been synthesized and characterized by H-1 NMR, C-13 NMR, IR, and X-ray single-crystal determination. The molecular geometry, vibrational frequencies and gauge including atomic orbital (CIAO) 1H and 13C NMR chemical shift values of III in the ground state have been calculated using the density functional method (B3LYP) with the 6-31G(d) basis set. The calculated results show that the optimized geometry can well reproduce the crystal structure, and the theoretical vibrational frequencies and chemical shift values show good agreement with experimental values. The energetic behavior of III in solvent media was examined using the B3LYP method with the 6-31G(d) basis set by applying the Onsager and the polarizable continuum model (PCM). The predicted nonlinear optical properties of III are greater than ones of urea. In addition. OFT calculations of molecular electrostatic potentials, frontier molecular orbitals and thermodynamic properties of III were carried out at the B3LYP/6-31G(d) level of theory. The title compound was screened for antibacterial, antifungal and antioxidant activities. (C) 2012 Elsevier B.V. All rights reserved.
dc.identifier.doi10.1016/j.saa.2012.07.082
dc.identifier.endpage934
dc.identifier.issn1386-1425
dc.identifier.issn1873-3557
dc.identifier.orcid0000-0003-1031-783X
dc.identifier.orcid0000-0002-3854-1537
dc.identifier.orcid0000-0002-3981-9748
dc.identifier.pmid22906969
dc.identifier.scopus2-s2.0-84962382602
dc.identifier.scopusqualityQ1
dc.identifier.startpage923
dc.identifier.urihttps://doi.org/10.1016/j.saa.2012.07.082
dc.identifier.urihttps://hdl.handle.net/11508/61555
dc.identifier.volume97
dc.identifier.wosWOS:000310395800123
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherPergamon-Elsevier Science Ltd
dc.relation.ispartofSpectrochimica Acta Part A-Molecular and Biomolecular Spectroscopy
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectN-cyclohexyl-2-[5-(4-pyridyl)-4-(p-tolyl)-4H-12,4-triazol-3-ylsulfanyl]-acetamide dihydrate
dc.subjectDFT
dc.subjectNMR
dc.subjectIR spectra
dc.subjectBiological effects
dc.titleN-cyclohexyl-2-[5-(4-pyridyl)-4-(p-tolyl)-4H-1,2,4-triazol-3-ylsulfanyl]-acetamide dihydrate: Synthesis, experimental, theoretical characterization and biological activities
dc.typeArticle

Dosyalar